Skip to content
Finasteride Info

Finasteride Info

Emerging evidence & commentary on risks of finasteride as a treatment for hair loss

  • Home
  • Drug information
    • Overview
    • Drug labels
    • How finasteride was invented
    • The alliance – special section
    • Historical timeline
  • Weighing risks
    • Weighing the risks of taking finasteride
    • 5-alpha syndrome (post-finasteride syndrome)
    • Firsthand reports
    • Adverse event data
    • Doctors expressing concerns
  • Research
    • Research overview
    • 2020–present
    • Earlier research
      • 2015–2019
      • 2010–2014
      • 2000–2009
      • 1942–1999
    • By system & function
    • – 5-alpha syndrome (post-finasteride syndrome)
    • – Effects on fertility
    • Special topics
    • Clinical trials
    • Grey literature
    • Related research
    • History of research
  • Resources
    • Resources – main
    • Physicians expressing concerns
    • News & media coverage
    • Historical timeline
    • The alliance – special section
    • Regulatory activity
    • Legal matters
    • The Merck files
    • Posts archive
    • About this site
    • Search

Etiopathology

A proposed explanation of lasting dysfunctions after use of finasteride or dutasteride

November 17, 2022February 24, 2022 by Montaigne

Men who previously took finasteride and dutasteride have reported sexual dysfunction, anxiety, depression, cognitive problems and other dysfunctions which have continued long after stopping the drug. This paper proposes an explanation for how these dysfunctions may develop.

Categories Research Tags Etiopathology, PD-5ARI, Research

Many websites tout the benefits of finasteride for treating hair loss, while downplaying the risks. This site is different: it puts risks in the foreground, accompanied by supporting evidence. Learn more

  • Considering taking finasteride or dutasteride for hair loss? See Weighing the risks

Navigator

  • 5-alpha syndrome
  • Adverse event data
  • Drug information
  • Drug origins
  • Firsthand reports
  • Media coverage
  • Regulation
  • Research
  • Search site
  • Site index
  • Timeline
  • Weighing the risks

Most popular

  • Research on penile alterations
  • Weighing the risks
  • Huberman podcast
  • Impact on hormone signaling
  • Bad outcomes in clinical trials
  • Influencers raising alarms
  • Physician views
  • Adverse event data
  • How was finasteride invented?
  • Research by system & function

Categories

  • Adverse event reports (17)
  • Diagnosis & treatment (1)
  • Doctor views (11)
  • Firsthand experiences (18)
  • History & context (13)
  • Merck (16)
  • News (8)
  • Regulation & FDA (7)
  • Research (24)
Tweets by FinasterideInfo
  • Home
  • Drug information
  • Research
  • Posts archive
  • Site index
  • Search
  • About & contact
  • Medical Disclaimer

Recent Posts

  • Response to Dr. Ralph Trüeb’s writings on post-finasteride syndrome
  • Appendix: response to Trüeb
  • Seeking a medical sign of genital numbness
  • Mid-year update
  • The lost men: how Merck, GSK papered over bad outcomes in trials

Post categories

  • Adverse event reports (17)
  • Diagnosis & treatment (1)
  • Doctor views (11)
  • Firsthand experiences (18)
  • History & context (13)
  • Merck (16)
  • News (8)
  • Regulation & FDA (7)
  • Research (24)

© 2020–2023 Finasteride Info  •  Privacy Policy
This website is not a substitute for professional medical advice, diagnosis or treatment. See Medical Disclaimer